The present invention involves both an apparatus and an associated method for confirming the presence or absence of closures in a closure nest inside an aseptic chamber. The apparatus comprises a topographical profiler disposed to monitor the closure nests. Vertical displacements in topographical maps obtained by the profiler are compared with information from a database about the nest and closure combinations. Vertical displacements falling outside predetermined upper and lower bounds are deemed absences of closures. The topographical profiler may be disposed outside the aseptic chamber. The system may be automated via a controller and suitable software. In some embodiments the nests and disposed in the monitored area by robotic articulated arms. In other embodiments the closure nests are moved by vacuum pickup systems. The system and method may also be employed to assess the suitability of a closure nest for closing in an aseptic chamber containers in a container nest.

Medication identification methods comprising depositing at least one medication in a compartment; identifying this one medication deposited in this compartment and analyzing at least one characteristic of said at least one medication; comparing this one characteristic of said at least one medication to medication signature characteristics to obtain an identified content for the compartment; comparing the identified content to a prescription; and allowing the medication to pass, via gravity, from the compartment to a pill box. Medication identification systems are also described.

A method for transferring medical products comprises the steps of conveying medical products on an oscillating conveyor having a plurality of conveying lanes arranged next to each other to a delivery area of the conveyor lanes and from the delivery area into at least one shaft; detecting a defective product in one of the conveying lanes; and activating a diverter device for defective products, which is arranged adjacent to the delivery area of this conveying lane, when a defective product is detected, wherein the diverter device, upon activation, is shifted or pivoted into an activated position, in which the diverter device is located in a transport path of the defective product.

An inspection device includes: an irradiator that irradiates an object with near-infrared light; a spectroscope that disperses reflected light from the irradiated object; an imaging device that takes a spectroscopic image of the reflected light; a processor that: obtains spectral data of a plurality of points on the object, based on the spectroscopic image; defines a group of similar spectral data from among the spectral data of the plurality of points; extracts a group having a largest number of spectral data from the defined group; calculates an average of the spectral data of the extracted group; and detects a type of the object using a predetermined analysis of the object, based on the average.

A drug packaging device includes a drug accommodating/dispensing unit that supplies various types of drugs, a drug packaging portion in which a drug supplied from the drug accommodating/dispensing unit is packaged in a packaging sheet, a drug packaging introducing member that drops the drug to be packaged into the packaging sheet in the drug packaging portion), a pooling portion that pools, upstream of this drug packaging introducing member, the drug, and a drug imaging device that captures an image of the drug in the pooling portion. The drug imaging device performs an imaging process of capturing an image of the drug in the pooling portion in a non-backlit state, and an imaging process of capturing an image of the drug in the pooling portion in a backlit state.

A tablet inspection and rejection verification module designed to integrate into a manufacturing line for tablets. The module being magnetically separable into a rejection portion, verification portion, and rejection collection portion of the module for easy replacement or cleaning. The module having a design to work in multi-channel tablet filling equipment. The module operates based on a predetermined good-bad inspection that communicates to the module that a tablet(s) needs to be removed from the filling process, and wherein the module upon rejection also has a method of verification of defective tablets moving in the good-tablet channel resulting in bottle rejection.

A device (100) for measuring light transmission through a suspected counterfeit pharmaceutical tablet (102) includes a laser source (110) configured to emit a light transmission through the pharmaceutical tablet (102). A light detector (120) is included in the device (100) configured to receive the light transmission and measure an amount of light passed through the suspected counterfeit pharmaceutical tablet (102). The amount of light transmitted through the suspected counterfeit pharmaceutical tablet (102) is indicative of an authentic or counterfeit.

The present invention generally relates to improved methods for the manufacture of inhalation powders. More particularly, aspects of the disclosure relate to methods for in-line monitoring of powder blending by Raman spectroscopy.

Measurement equipment can be used for control with spectroscopic analysis of individual moving objects. The measurement equipment includes a probe with a surface, from which one or more illumination optical fibres and measurement optical fibres emerge. The optical fibres are arranged so that at least one of the second acceptance cones intersects at least one first acceptance cone at less than 10 mm from the surface. The measurement equipment includes a triggering device detecting the objects upstream of the probe to activate or deactivate the observation of the objects by the probe.

A measurement system comprising one or more semiconductor diodes configured to penetrate tissue comprising skin. The detection system comprising a camera, which may also include a direct or indirect time-of-flight sensor. The detection system synchronized to the pulsing of the semiconductor diodes, and the camera further coupled to a processor. The detection system non-invasively measuring blood within the skin, measuring hemoglobin absorption between 700 to 1300 nm, and the processor deriving physiological parameters and comparing properties between different spatial locations and variation over time. The semiconductor diodes may comprise vertical cavity surface emitting lasers, and the detection system may comprise single photon avalanche photodiodes. The measurement system may be used to observe eye parameters and differential blood flow. The system may be used with photo-bio-modulation therapy, or it may be used in advanced driver monitoring systems for multiple functions including head pose, eye tracking, facial authentication, and smart restraint control systems.